this page only  
Join BIO   |   Member Directory   |    Contact BIO    
Biotechnology Industry Organization

Home
About BIO
Conferences & Events
Past BIO Events
Industry Calendar
State/Int'l Calendar
Members.BIO.org
BIO News Online
BIO Bulletins
Suggestion Box
Membership Directory
BIO Videos
News & Media
BIO Blogs & Podcasts
National Issues
Health
Food & Agriculture
Industrial & Environmental
Bioethics
Intellectual Property
Regulatory
• Tax & Financial
State & Local Issues
State by State Initiatives
Letters, Testimony & Comments
Speeches & Publications
Industry At-a-Glance
Business & Finance
BIO News


Saturday, November 21, 2009

Tax & Financial | R&D Tax Credit Archive

H.R.1308
Tax Relief, Simplification, and Equity Act of 2003
Read the bill text

Orphan Drug Tax Credit Fact Sheet
Clarification Needed to Accelerate Research in Rare Diseases (Apr. 11 2003)
Read the fact sheet

Orphan Drug Tax Credit Support Letter
BIO Letter expressing strong support to Representative Kevin Brady (R-Tex) (Mar. 5, 2003)
Read the letter

BIO Comments to the SEC
Proposal to Release R&D Firms From 'Investment Company' Limits (January 9, 2003)
Read the comments (1.9 MB PDF).

Testimony of Harry H. Penner
President and CEO of Neurogen Corporation testified on behalf of the Biotechnology Industry Organization before the Oversight Committee of the House Ways and Means Committee regarding the Research and Experimentation Tax Credit (May 10, 1995)
Read the testimony

Current R&D Tax Credit Information
Browse the R&D Tax Credit issue page

contact us | terms of use | privacy policy
© 2009 | Biotechnology Industry Organization | 1201 Maryland Ave., SW, Ste. 900 | Washington, D.C. 20024